Ntp Monograph: Identifying Research Needs For Assessing Safe Use Of .

1y ago
1 Views
1 Downloads
1.07 MB
60 Pages
Last View : 27d ago
Last Download : 3m ago
Upload by : Annika Witter
Transcription

NTP MONOGRAPH:IDENTIFYING RESEARCH NEEDS FOR ASSESSINGSAFE USE OF HIGH INTAKES OF FOLIC ACIDAugust 1, 2015Office of Health Assessment and TranslationDivision of the National Toxicology ProgramNational Institute of Environmental Health SciencesNational Institutes of HealthU.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

TABLE OF CONTENTSTable of Contents .IIList of Table and Figures . IVContributors . VAbbreviations . VIIIAbstract .IX1.0Introduction .11.11.2Overall Objective . 1Organization of Background Material . 21.2.1 Methods . 21.2.2 Health Effects Summaries . 21.2.3 Expert Panel Report. 21.2.4 Supplementary Material . 21.2.5 Web-based Health Effects Data . 32.0Background .43.0Methods .43.13.23.33.44.0High Priority Health Effect Categories . 134.14.24.34.45.0Literature Screen . 63.1.1 Criteria for Identifying Relevant Studies . 63.1.2 Search Methods for Identification of Studies . 73.1.3 Selection of Studies . 8Detailed Tagging of Human Studies . 11Outcome Prioritization . 11Data Extraction . 12Cancer Pooled and Meta-analyses . 13Cognition and Vitamin B12 . 15Hypersensitivity-related Outcomes. 17Thyroid and Diabetes-related Disorders . 19Other Health Effect Categories . 215.15.25.35.45.55.65.75.8Cardiovascular Outcomes. 21Twinning and Multiple Births . 21Autism . 22Other Neurological Outcomes. 22Other Immunological Outcomes . 22Other Endocrine and Metabolic Disease Outcomes . 23Other Reproductive Outcomes . 23Mortality . 23Identifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidII

6.0Expert Panel Report . 246.16.26.36.46.56.66.77.0Introduction and Expert Panel Charge . 24Introductory Presentations . 24Subpanels’ Reports to the Full Panel and Discussion . 266.3.1 Cancer Subpanel . 276.3.2 Cognition in Conjunction with Vitamin B12 Deficiency Subpanel . 296.3.3 Hypersensitivity-Related Outcomes Subpanel . 316.3.4 Thyroid and Diabetes-Related Disorders Subpanel . 34Discussion of Common Themes . 36Public Comments. 36Full Panel Votes . 38Approval of the Expert Panel Report by the Chair . 40References. 41Appendix 1: Literature Search Method . 43Appendix 2: Criteria for Screening of Studies . 45Appendix 3: Data Extraction Elements . 47Individual Epidemiology Studies . 47Pooled or Meta-analyses . 48Appendix 4: Expert Panel Members and Meeting Attendees . 49Identifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidIII

LIST OF TABLE AND FIGURESTABLE:Table 1. Number of studies identified within each health effect category. Studies could beclassified under more than one category so the sum across categories will be higher than theoverall total. . 10FIGURES:Figure 1: Example figure. Eczema studies of maternal folate intake, ordered by increasing dose(No dose reports for (Nwaru et al. 2011); total folate intake results reported as not statisticallysignificant.) . 4Figure 2. Publication rates over time. Number of studies identified by the literature search andhand collected per year (cumulative total 28,580). . 5Figure 3. Selection of Studies. Diagrams the flow of studies through the screening process,including reasons for the exclusion of studies (adapted from Moher et al. 2009). . 9Figure 4. Number of studies by year for the included studies and by each major health effectcategory. . 10Figure 5. Cancer studies identified by year (since 1980) including the number of meta-analyses. 13Figure 6. Number of neurological and cognition and vitamin B12-related studies by year since1980 . . 15Figure 7. Number of immunological and hypersensitivity-related studies by year since 1980. . 17Figure 8. Number of endocrine and metabolism studies by year since 1980. . 19Identifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidIV

CONTRIBUTORSOffice of Health Assessment and Translation (OHAT), NIEHS/DNTPConducted scientific evaluation, screened literature, and prepared the NTP MonographAbee L. Boyles, PhD (Project Lead)Andrew A. Rooney, PhD (Deputy Director, OHAT)Vickie R. WalkerKristina A. Thayer, PhD (Director, OHAT)Office of Dietary Supplements (ODS), NIH/ODProvided input on project developmentPaul M. Coates, PhD (Director)Elizabeth A. Yetley, PhD (Scientific Consultant)Office of Scientific Information Management (OSIM), NIEHS/ODDDeveloped and conducted the initial literature search and updatesStephanie D. Holmgren, MSLIS, MBAProgram Operations Branch (POB), NIEHS/DNTPDeveloped and maintained the HAWC resourceAndy Shapiro, MPHOffice of Liaison, Policy and Review (OLPR), NIEHS/DNTPManaged expert panel meetingYun Xie, PhD (Designated Federal Official)Denise LaskoAnna Lee MosleyMary Wolfe, PhD (Director, OLPR and Deputy Division Director for Policy)Integrated Laboratory Systems, Inc.Performed detailed tagging of human studiesClaudine A. Gregorio, MANeepa Y. Choski, PhDMDB, Inc.Developed and conducted the initial literature searchLesley Skalla, MSLS, PhDSocial & Scientific SystemsPerformed detailed tagging and extracted data from studies into the HAWC databaseGrace Megumi Sotherden, MSAnna Ciesielski Jones, MPHFikri Yucel, MAIdentifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidV

Steering CommitteeProvided input on the prioritization of topics and expert panel compositionNicole F. Dowling, PhDAssociate Director for Science, Division of Birth Defects andDevelopmental Disabilities, National Center on Birth Defects andDevelopmental Disabilities, Centers for Disease Control andPrevention, Atlanta, GAAmanda MacFarlane, PhDResearch Scientist, Section Head, Micronutrient Research, NutritionResearch Division, Health Canada, Ottawa, OntarioEdward McCabe, MD, PhDSenior Vice President and Chief Medical Officer, March of DimesFoundation, White Plains, NYLinda D. Meyers, PhDSenior Science Advisor, American Society for Nutrition, Bethesda, MDRobert M. Russell, MDProfessor Emeritus of Medicine and Nutrition, Tufts University,Medford, MAYu (Janet) Zang, PhD, DABTReview Toxicologist, Office of Food Additive Safety, Center for FoodSafety and Applied Nutrition, U. S. Food and Drug Administration,College Park, MDRapporteursAssisted subpanels with summarizing recommendations and preparing presentationsKara Koehrn, MEMProgram Analyst, Toxics Release Inventory; US EnvironmentalProtection Agency, Washington, DCAdam J. Kuszak, PhDScience and Technology Policy Fellow at AAAS, Office of DietarySupplements, National Institutes of Health, Bethesda, MDKatherine E. Pelch, PhDPostdoctoral Fellow, Office of Health Assessment and Translation,National Toxicology Program, National Institute of EnvironmentalHealth Sciences, National Institutes of Health, Durham, NCPaul R. Thomas, EdD, RDNScientific Consultant, Office of Dietary Supplements, NationalInstitutes of Health, Bethesda, MDExpert PanelMade research recommendations based on review of the literatureJoseph M. Braun, PhDAssistant Professor, Department of Epidemiology, School of PublicHealth, Brown University, Providence, RITim Byers, MDAssociate Dean for Public Health Practice, Director, Center for PublicHealth Practice, Colorado School of Public Health, University ofColorado Denver, Aurora, CORobert Clarke, MDProfessor of Epidemiology and Public Health, Clinical Trial Service Unitand Epidemiological Studies Unit, Course Director of MSc in GlobalHealth Science, Nuffield Department of Population Health, Universityof Oxford, Oxford, Oxfordshire, UKTodd M. Gibson, PhDAssistant Member, Department of Epidemiology and Cancer Control,St. Jude Children's Research Hospital, Memphis, TNIdentifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidVI

Jesse F. Gregory, III, PhDProfessor, Food Science and Human Nutrition Department, Universityof Florida, Gainesville, FLPaul F. Jacques, DScDirector, Professor, and Senior Scientist, Nutritional EpidemiologyProgram, Jean Mayer USDA Human Nutrition Research Center onAging, Tufts University, Boston, MAYoung-In Kim, MDProfessor of Medicine and Nutritional Sciences, University of Toronto;Senior Scientist, Keenan Research Center for Biomedical Science of St.Michael's Hospital; Staff Gastroenterologist, St. Michael's HospitalToronto, ON, CanadaJoel B. Mason, MDProfessor of Medicine, School of Medicine, Professor of Nutrition,School of Nutritional Science and Policy, Tufts University, Boston, MAElizabeth Matsui, MDAssociate Professor of Pediatrics, Epidemiology, and EnvironmentalHealth Sciences, Johns Hopkins University, Baltimore, MDJoshua W. Miller, PhDProfessor and Chair, Department of Nutritional Sciences, RutgersUniversity, New Brunswick, NJJames L. Mills, MD, MSSenior Biomedical Research Service Scientist, Eunice Kennedy ShriverNational Institute of Child Health and Human Development, NationalInstitutes of Health, Bethesda, MDAnne M. Molloy, PhDAssociate Professor, School of Medicine, School of Biochemistry andImmunology, Trinity College Dublin, Dublin, IrelandMartha C. Morris, ScDDirector, Section of Nutrition and Nutritional Epidemiology, Professor,Department of Internal Medicine, Rush University, Chicago, ILJeanne I. Rader, PhDRetired December 2013, Office of Regulatory Science, Center for FoodSafety and Applied Nutrition, Food and Drug Administration, CollegePark, MDBarry Shane, PhDProfessor of Nutrition, Department of Nutritional Sciences andToxicology, University of California, Berkeley, Berkeley, CAPatrick J. Stover, PhDProfessor and Director, Division of Nutritional Sciences, CornellUniversity, Ithaca, NYMiroslav Stýblo, PhDProfessor, Department of Nutrition, Gillings School of Global PublicHealth, University of North Carolina at Chapel Hill, Chapel Hill,NCHenk van Loveren, PhDProfessor of Immunotoxicology, Centre for Health Protection,National Institute of Public Health and the Environment, Bilthoven,the Netherlands; Department of Toxicogenomics, MaastrichtUniversity, Maastricht, the NetherlandsExpert Panel ChairModerated the meeting and developed the Expert Panel ReportCutberto Garza, MD, PhDVisiting Professor, Bloomberg School of Public Health, Johns HopkinsUniversity; Visiting Professor, Milken Institute School of Public Health,George Washington University; University Professor, Boston CollegeChestnut Hill, MAIdentifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidVII

ISMARBCRDAULWENBITWHONameCenters for Disease Control and PreventionContinuing Survey of Food Intakes by IndividualsDietary folate equivalentDivision of the National Toxicology ProgramHealth Assessment Workspace CollaborativeHomeostatic model assessmentInstitute of MedicineMedical Subject HeadingNational Institute of Environmental Health SciencesNational Institutes of HealthNorwegian Vitamin TrialNeural tube defectNational Toxicology ProgramOffice of Dietary SupplementsOffice of Health Assessment and TranslationOffice of Liaison, Policy and ReviewOffice of Science Information ManagementPopulation, Exposure, Comparator and OutcomePopulation, Intervention, Comparator and OutcomePreferred Reporting Items for Systematic Reviews and Meta-AnalysesRed blood cellRecommended Dietary AllowanceTolerable upper intake levelWestern Norway B Vitamin Intervention TrialWorld Health OrganizationIdentifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidVIII

ABSTRACTFolate is a water-soluble B-complex vitamin required for cell growth and division, and adequate folateintake is necessary to prevent a wide variety of health conditions. Some published studies have raisedconcerns about the safe use of folic acid, a synthetic form of folate, above 400 µg.* In order to identifypotential research needs for evaluating the safe use of folic acid at an intake level higher than thecurrent RDA (referred to as “high intake” in this document), the National Toxicology Program (NTP)partnered with the NIH Office of Dietary Supplements (ODS) to convene an expert panel to evaluate thecurrent state of the science.As background material for the expert panel, published literature relevant for evaluating the potentialfor health effects associated with high doses of folic acid was collected and summarized. Due to thelarge number of published studies on folate and folic acid, screening of the literature using systematicreview methodology was undertaken to transparently identify, select, and group the studies by potentialhealth effects areas.A steering committee of individuals knowledgeable about the folic acid health literature was formed tosuggest areas where data indicate potential adverse health effects associated with high intakes or bloodlevels of folic acid. Four general health effect categories were identified (cancer, cognition in conjunctionwith vitamin B12 deficiency, hypersensitivity-related outcomes, and thyroid and diabetes relateddisorders). This document includes an explanation of the methods used to identify and collect therelevant literature. The human study data for these health effects were summarized and are availableonline (https://hawcproject.org/assessment/public/) and in the Supplementary Material(http://ntp.niehs.nih.gov/go/749003) as a resource for the expert panel. Supporting literature fromrelevant animal and in vitro studies are listed in Supplementary Material. This document also presentsthe reasoning of the steering committee as to why other health effects identified in the literature werenot considered high priority areas of focus for this review.On May 11-12, 2015, the National Toxicology Program (NTP) and Office of Dietary Supplements (ODS)convened an expert panel to identify research needs related to the safe use of high intakes of folic acidbased on consideration of the state of the science. The expert panel was charged to (1) identify theareas of consistency and areas of uncertainty in the available science, (2) identify research needs basedon review of the available science, and (3) propose research approaches for addressing the researchneeds and gaps in the available science. The Panel’s recommendations did not require consensus,included minority opinions, and do not necessarily represent the opinion of NTP or ODS. This NTPMonograph includes the expert panel report as Chapter 6.0.*Text was changed from "a synthetic form of folate, above the Recommended Dietary Allowance (RDA) of 400µg" to "a synthetic form of folate, above 400 µg" on September 16, 2015.Identifying Research Needs for Assessing Safe Use of High Intakes of Folic AcidIX

1.0INTRODUCTIONThe National Toxicology Program (NTP) 1 in conjunction with the NIH Office of Dietary Supplements(ODS) 2 held an expert panel meeting to identify research needs based on consideration of the state ofthe science from published literature related to the safe use of high intakes of folic acid. The benefit ofsupplemental folic acid for pregnant women to prevent neural tube defects in their children is wellestablished; at the same time, there is interest in identifying and understanding any potential adversehealth impacts from high intakes of folic acid. This project aimed to inform the development of aresearch agenda for evaluating the safe use of high intakes of folic acid.Due to the vastness of the research on folate and folic acid, 3 screening of the literature using systematicreview methodology was undertaken to identify potential adverse health effects for which furtherresearch might be warranted. This document (1) outlines the approach used to identify the literature,select relevant studies, and group data by health effect categories; (2) describes how high priority healtheffect categories were identified; and (3) summarizes the human literature in the high priority and otherhealth effect categories, including discussion of why the health effects were or were not considered highpriority areas of focus for this evaluation.1.1Overall ObjectiveThe objective of this project was to identify research needs and outline research approaches forevaluating the safe use of high intakes of folic acid. This objective was developed by the NTP Office ofHealth Assessment and Translation, National Institute of Environmental Health Sciences and ODS withinput from the steering committee and staff in the Centers for Disease Control and Prevention Divisionof Birth Defects and Developmental Disabilities. This effort was informed by this state-of-the-scienceliterature review and facilitated by a panel of qualified experts convened by NTP and ODS. Following theexpert panel meeting, the NTP Monograph was finalized with the expert panel’s report as Chapter 6.0and published on the NTP website (http://ntp.niehs.nih.gov/go/38144).To achieve this objective, theexpert panel was charged to: Identify the areas of consistency and areas of uncertainty in the available scienceIdentify research needs based on review of the available sciencePropose research approaches for addressing the research needs and gaps in the availablescience1The NTP is a federal, interagency program whose goal is to safeguard the public by identifying substances in theenvironment that may affect human health. NTP is headquartered at the National Institute of EnvironmentalHealth Sciences, which is part of the National Institutes of Health. For more information about NTP and itsprograms, visit http://ntp.niehs.nih.gov/.2The mission of the ODS is to strengthen knowledge and understanding of dietary supplements by evaluatingscientific information, stimulating and supporting research, disseminating research results, and educating thepublic to foster an enhanced quality of life and health for the U.S. population. For more information about ODSand its programs, visit http://ods.od.nih.gov/.3Over 29,000 references identified in Pubmed search using the MeSH term “folic acid” in January 2015Identifying Research Needs for Assessing Safe Use of High Intakes of Folic Acid1

1.2Organization of Background MaterialThis document was prepared by the NTP Office of Health Assessment and Translation for use asbackground material for the expert panel and public. The focus is on how the human health effectsliterature was collected and includes a brief summary of the identified literature. The health benefit offolic acid in preventing neural tube defects is well established, and this document does not include areview of that literature or consider dose-related effects of this protective effect. This document alsodoes not include information on sources of folic acid or current intake or measured blood levels. Insummarizing only the human literature, this background document also does not include relevantinformation on biological plausibility provided by relevant animal and in vitro experimental studies. Listsof such relevant studies are provided in the Supplementary Material(http://ntp.niehs.nih.gov/go/749003). The Supplementary Material provides bibliographic lists ofrelevant supporting studies. This document has been reviewed internally for clarity and accuracy prior torelease to the public.1.2.1 MethodsThis document has been prepared using the principles of systematic review methodology tocomprehensively identify relevant studies. As such, the Methods section provides a description of thisprocess in a manner similar to a systematic review protocol. Scientific judgments made by NTP, ODS,and the steering committee during the development of this project are documented with scientificjustification for the decisions.1.2.2 Health Effects SummariesChapter 4.0 High Priority Health Effect Categories includes summaries of the information collected forthe four health effect categories of focus for the expert panel. Each section includes a brief introductionto the topic, what literature was identified, why the topic was considered high priority, and potentialissues the expert panel may discuss when considering the consistency and uncertainty in the literature.There is also a figure of the number of citations by year since 1980 and an example graph of resultsacross studies with similar endpoints.For health effect categories not considered high priority, chapter 5.0 Other Health Effect Categoriesincludes a brief description of why these health effects were not considered as pressing topics for theexpert panel’s consideration.1.2.3 Expert Panel ReportChapter 6.0 is the report written and approved by the Expert Panel and does not necessarily representthe opinion of NTP or ODS. The panel voted unanimously (18 yes, 0 no, 0 abstain) to accept the researchrecommendations and issues relevant to all four subpanel’s recommendations after some revision inresponse by comments from the full panel.1.2.4 Supplementary MaterialFor each of the high priority health effect categories, Study Summaries provide detailed informationabout the design and results as reported in the publications. Presenting each study in a consistentmanner facilitates comparison of results across the literature base.Reference Lists are provided for the studies captured in the literature search and screen:Identifying Research Needs for Assessing Safe Use of High Intakes of Folic Acid2

Human studies of High Priority Health EffectsAnimal studies relevant to the High Priority Health Effect CategoriesIn vitro studies relevant to the High Priority Health Effect CategoriesHuman studies in the Other Health Effect CategoriesPooled and meta-analyses for High Priority and Other Health Effect CategoriesSupplementary Materials are available online (http://ntp.niehs.nih.gov/go/749003).1.2.5 Web-based Health Effects DataHealth Assessment Workspace Collaborative (HAWC, https://hawcproject.org/) is an online contentmanagement system for conducting human-health risk assessments. HAWC allows users to have astandardized and transparent presentation of the data from each study and create customized datapresentations in both graphical and textual formats. As a freely available online resource, it also allowsthe public to view the studies in the same manner as the expert panel.As part of the background materials, NTP extracted data on health outcomes within each of the fourhigh priority health effect categories. Details of study design, folate measurement (intake or bloodlevel), outcome assessment and results are presented in HAWC as four projects (one for each category).Visualizations includes graphs of results from across studies (see Figure 1) and are available within eachproject in HAWC. The expert panel members used this online tool to browse graphs of results acrossstudies and interactively explore additional details about each study.The four folic acid projects are publically accessible nal information about the HAWC resource can be found here(https://hawcproject.org/user/new/).An example of a graph available in HAWC under Visualizations is provided (Figure 1). The graphs areinteractive allowing users to click on results and text to access additional information in a pop-upwindow (e.g., to see how the outcome was diagnosed, what adjustments were made in the statisticalanalysis, etc.) or navigate to the full study summary information. All of the data included in these graphsare also available in the Study Summaries in the Supplementary ifying Research Needs for Assessing Safe Use of High Intakes of Folic Acid3

Figure 1: Example figure. Eczema studies of maternal folate intake, ordered by increasing dose (No dosereports for (Nwaru et al. 2011); total folate intake results reported as not statistically significant.)2.0BACKGROUNDFolate is a general term for this water-soluble B-complex vitamin, which humans require for thesynthesis of nucleic acids and to provide methyl groups for biochemical reactions within cells (NationalResearch Council 1998). These functions are needed for every

IDENTIFYING RESEARCH NEEDS FOR ASSESSING SAFE USE OF HIGH INTAKES OF FOLIC ACID . August 1, 2015 . Office of Health Assessment and Translation . Division of the National Toxicology Program . National Institute of Environmental Health Sciences . National Institutes of Health . U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Related Documents:

Hortonworks DataFlow June 6, 2018 3 SLES zypper install ntp chkconfig ntp on Ubuntu apt-get install ntp update-rc.d ntp defaults Debian apt-get install ntp update-rc.d ntp defaults 1.1.5. Check DNS and NSCD All hosts in your system must be configured for both forward and and reverse DNS.

Step 2 [no] ntp enable Enables or disables the NTP protocol on the Cisco CG-OS router. NTP is enabled by default. Step 3 show ntp status (Optional) Displays the status of the NTP application. Step 4 copy running-config startup-config (Optional) Saves the change by copying the running configuration to the startup configurationFile Size: 243KB

Completed NTP Reports and Publications . NTP studies are published in various NTP report series after undergoing peer review. NTP reports published in FY 2018 or expected for peer review in FY 2019 are listed. Full citations for NTP reports, journal publications, and book chapters published during FY 2018 are provided as an appendix to this .

2-Aug-04 2 Introduction zNetwork Time Protocol (NTP) synchronizes clocks of hosts and routers in the Internet. zNIST estimates 10-20 million NTP servers and clients deployed in the Internet and its tributaries all over the world. Every Windows/XP has an NTP client. zNTP provides nominal accuracies of low tens of milliseconds on WANs, submilliseconds on LANs, and submicroseconds using a .

Network Time Protocol (NTP) is used for automatic time synchronization. Cisco networks use NTP to make timekeeping accurate and coordinated across the board. The use of NTP is highly recommended for security because having accurate time is important for intrusion and forensic analysis. NTP is typically deployed in a hierarchical fashion.

Cisco IOS XR System Management Command Reference for the Cisco CRS Router, Release 5.1.x 4 NTP Commands access-group (NTP) . Cisco IOS XR System Management Command Reference for the Cisco CRS Router, Release 5.1.x 19 NTP Commands max-associations. multicast client

The National Toxicology Program . NTP is the nation’s premier federal program for testing . and evaluating agents of public health concern in our environment. NTP develops and applies tools of modern toxicology and molecular biology to evaluate substances that may potentially cause harm to human health. For information about NTP, visit

adventure tourism (ISO 21101 and TR 21102)2 addresses adventure travel specifically, and none of these standards or quality assurance systems cover all the aspects necessary for excellent adventure travel guiding. In the absence of a global qualification and performance standard, a variety of approaches to managing adventure travel guiding can be